Sort
50,496 grants matching “lung cancer”
Enhanced treatment of breast cancer via biodegradable polymer nanoparticles
$391,826David Peter Cormode · University Of Pennsylvania · R21 · FY2025 · CA
Role of GATA3 in transcriptional pathways suppressing breast cancer metastasis
$391,822Zena Werb · University Of California, San Francisco · R01 · FY2019 · CA
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$391,800Joseph M Fox · University Of Delaware · P20 · FY2021 · GM
Novel bisphosphonates for multiple myeloma therapy
$391,786Alexander Karpeisky · Mbc Pharma, Inc. · R44 · FY2008 · CA
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$391,766Andrea Facciabene · University Of Pennsylvania · R01 · FY2019 · CA
ANTITUMOR PROPERTIES OF DISCODERMOLIDE AND DERIVATIVES
$391,761Harbor Branch Oceanographic Inst, Inc. · R01 · FY2000 · CA
Noninvasive detection of circulating RNAs for lung cancer early detection and prognosis
$391,724Yun Wu · State University Of New York At Buffalo · R33 · FY2017 · CA
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy
$391,721Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2025 · CA
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy
$391,721Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2022 · CA
Defining the Critical Function and Regulation of NNMT in Breast Cancer Progression and Metastasis
$391,709Binhua P Zhou · University Of Kentucky · R01 · FY2025 · CA
Establishing the clinical utility of cell-free tumor DNA methylation profiling as a reliable liquid biopsy approach in brain tumors
$391,675Gelareh Zadeh · University Health Network · R01 · FY2025 · CA
ApoVax104-TB as a Novel Vaccine for Tuberculosis
$391,672Kathryn J. Macleod · Apovax, Inc. · R43 · FY2008 · AI
Targeting epithelial membrane protein 2 (EMP2) in retinopathy of prematurity
$391,647Alison Chu · University Of California Los Angeles · R01 · FY2025 · EY
Targeting epithelial membrane protein 2 (EMP2) in retinopathy of prematurity
$391,647Alison Chu · University Of California Los Angeles · R01 · FY2024 · EY
Targeting epithelial membrane protein 2 (EMP2) in retinopathy of prematurity
$391,647Alison Chu · University Of California Los Angeles · R01 · FY2023 · EY
Regulation and Targeting of CD24 in Bladder Cancer
$391,637Dan Theodorescu · Cedars-Sinai Medical Center · R01 · FY2019 · CA
PROMINENT - IARC
$391,529Paul Joseph Brennan · International Agency For Res On Cancer · OT2 · FY2022 · CA
Preventing Melanoma Metastasis by Targeting Lipid Vulnerabilities in Lymph
$391,523Jessalyn Ubellacker · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · CA
Comparative Effectiveness of Surgical Treatments for Lung Cancer in the Elderly
$391,520Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · HS
Cancer Care and Outcomes for Disabled Medicare Patients
$391,517Beth Israel Deaconess Medical Center · R01 · FY2003 · CA
DNA Methylation Marks of COPD
$391,515Edwin K Silverman · Brigham And Women'S Hospital · P01 · FY2015 · HL
Ancillary T Cell Based Studies in SPIROMICS
$391,478Farrah Kheradmand · Baylor College Of Medicine · R01 · FY2015 · HL
Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy
$391,467Brian T. Cunningham · University Of Illinois At Urbana-Champaign · R33 · FY2023 · CA
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target
$391,466Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Statistical Methods and Validation Analyses for the Integration of External Data in Clinical Trials
$391,445Lorenzo Trippa · Dana-Farber Cancer Inst · R01 · FY2021 · LM